The court was hearing a petition filed by Nestle against FSSAI's June 5 order banning nine variants of Maggi, and Maharashtra government's order prohibiting their sale.
Read more from our special coverage on "NESTLE MAGGI CONTROVERSY"
"If they (Nestle) had problems with the FDA report of laboratory tests showing lead content in Maggi, they could have told us, following which we could have referred the case to other accredited labs. Instead, the company challenged our authority," argued FDA counsel Darius Khambata.
He further said, to a question by the judges, that of the 20 samples which were sent to the labs, only five tested positive.
To another question by the division bench of justices V M Kanade and B P Colabawalla, Khambata said FDA had tested only two variants of Maggi, but banned all the nine variants available in the market. He would continue the argument tomorrow.
The lawyer of Food Safety Standards Authority of India (FSSAI) had earlier argued that it had not banned Maggi, but only asked the company to stop the manufacture and sale as it contained lead beyond the permissible limit.
FSSAI also said that it was ready to give a hearing to the company.
Both FSSAI and FDA have claimed that they had issued notices to Nestle India keeping in mind the health hazards the product may have had due to the high lead content.
Nestle has argued that a particular batch may have contained lead beyond permissible limit but the blanket ban was "unfair and illegal".
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
)